NASDAQ:HALO | Net Margin | HALOZYME THERAPEUTICS, INC.

Complete source-backed net margin history.

Available history
2009-12-31 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-3047.80%
2026-03-3139.83%
2025-12-31-31.34%
2025-09-3049.46%
2025-06-3050.71%
2025-03-3144.59%
2024-12-3145.98%
2024-09-3047.23%
2024-06-3040.30%
2024-03-3139.22%
2023-12-3137.12%
2023-09-3037.88%
2023-06-3033.82%
2023-03-3124.43%
2022-12-3131.79%
2022-09-3029.49%
2022-06-3014.89%
2022-03-3151.25%
2021-12-3165.46%
2021-09-30186.99%
2021-06-3067.02%
2021-03-3131.33%
2020-12-3160.12%
2020-09-3055.43%
2020-06-3046.75%
2020-03-31-24.07%
2019-12-31-64.10%
2019-09-30-54.11%
2019-06-30-37.36%
2019-03-313.15%
2018-12-31-3.53%
2018-09-30-108.98%
2018-06-30-65.03%
2018-03-31-88.95%
2017-12-3165.35%
2017-09-304.31%
2017-06-30-91.15%
2017-03-31-111.26%
2016-12-31-70.22%
2016-09-30-90.87%
2016-06-30-80.62%
2016-03-31-46.63%
2015-12-318.27%
2015-09-30-117.71%
2015-06-306.96%
2015-03-31-80.94%
2014-12-31-17.36%
2014-09-30-138.85%
2014-06-30-88.51%
2014-03-31-221.86%
2013-12-31-175.92%
2013-09-30-120.48%
2013-06-30-158.52%
2013-03-31-162.99%
2012-12-31-20.22%
2012-09-30-375.04%
2012-06-30-180.75%
2012-03-31-203.21%
2011-12-31-763.76%
2011-09-3022.51%
2011-06-3013.44%
2011-03-31-127.73%
2010-12-31-472.88%
2010-09-30-365.36%
2010-06-30-378.14%

Annual Net Margin

DateNet Margin
2025-12-3122.69%
2024-12-3143.74%
2023-12-3133.96%
2022-12-3130.62%
2021-12-3190.84%
2020-12-3148.24%
2019-12-31-36.86%
2018-12-31-52.90%
2017-12-3119.89%
2016-12-31-70.23%
2015-12-31-23.86%
2014-12-31-90.76%
2013-12-31-152.34%
2012-12-31-126.53%
2011-12-31-35.25%
2010-12-31-390.79%
2009-12-31-426.88%